NovoCure Limited (NVCR) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-26 11:17:50 ET
NovoCure Limited (NVCR) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST
Company Participants
Adam Daney
William Doyle - Executive Chairman
Frank Leonard - Chief Executive Officer
Christoph Brackmann - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
NovoCure Limited (NVCR) Q4 2025 Earnings Call Transcript
NovoCure Limited
NASDAQ: NVCR
NVCR Trading
-2.85% G/L:
$12.775 Last:
483,163 Volume:
$12.60 Open:
NVCR Latest News
March 02, 2026 07:00:00 am
Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer
February 26, 2026 07:00:00 am
Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update
NVCR Stock Data
$1,170,211,701
105,800,576
0.07%
77
N/A
Medical Equipment & Supplies
Healthcare
JE
St. Helier
